NPM1 Minimal Residual Disease Detection at Any Time by Clinical Next Generation Sequencing Predicts Poor Survival in Acute Myeloid Leukemia

被引：0
|
作者：
Sallman, D. [1 ]
Xie, Z. [1 ]
Chan, O. [1 ]
Shao, R. [2 ]
Song, J. [2 ]
Hussaini, M. O. [2 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Pathol & Lab Med, Tampa, FL USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2024年 / 162卷
关键词：
D O I：
10.1093/ajcp/aqae129.182
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
aqae129.18
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] Clinical Deep Sequencing of NPM1 for Minimal Residual Disease Detection in Acute Myeloid Leukemia
    Hoyle, Eric
    Murillo, Lena
    Nesbitt, Shannon
    Zhou, Yi
    Wood, Brent L.
    Salipante, Stephen J.
    Wu, David
    LABORATORY INVESTIGATION, 2016, 96 : 353A - 353A
  • [2] Clinical Deep Sequencing of NPM1 for Minimal Residual Disease Detection in Acute Myeloid Leukemia
    Hoyle, Eric
    Murillo, Lena
    Nesbitt, Shannon
    Zhou, Yi
    Wood, Brent L.
    Salipante, Stephen J.
    Wu, David
    MODERN PATHOLOGY, 2016, 29 : 353A - 353A
  • [3] Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing
    Salipante, Stephen J.
    Fromm, Jonathan R.
    Shendure, Jay
    Wood, Brent L.
    Wu, David
    MODERN PATHOLOGY, 2014, 27 (11) : 1438 - 1446
  • [4] Next-Generation Sequencing of NPM1 for Minimal Residual Disease Monitoring in Leukemia Patients
    Carson, A. R.
    Xie, Z.
    McClain, V.
    Miller, J. E.
    Stenzel, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 967 - 967
  • [5] Clinical Relevance of Minimal Residual Disease Monitroing in Npm1 Mutated Acute Myeloid Leukemia
    Doehner, K.
    ANNALS OF HEMATOLOGY, 2013, 92 : S39 - S39
  • [6] EVALUATION OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA WITH NPM1 MARKER
    Alizadghandforoush, N.
    Nadali, F.
    Rostami, S.
    Chahardouli, B.
    Ghadimi, H.
    Ghasemi, A.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    HAEMATOLOGICA, 2015, 100 : 657 - 658
  • [7] Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations
    Thol, Felicitas
    Koelking, Britta
    Damm, Frederik
    Reinhardt, Katarina
    Klusmann, Jan-Henning
    Reinhardt, Dirk
    von Neuhoff, Nils
    Brugman, Martijn H.
    Schlegelberger, Brigitte
    Suerbaum, Sebastian
    Krauter, Juergen
    Ganser, Arnold
    Heuser, Michael
    GENES CHROMOSOMES & CANCER, 2012, 51 (07): : 689 - 695
  • [8] Minimal residual disease detection in acute myeloid leukemia (AML) by mutant nucleophosmin (NPM1) early predicts impending relapse
    Shayegi, N.
    Kramer, M.
    Bornhaeuser, M.
    Schaich, M.
    Schetelig, J.
    Platzbecker, U.
    Roellig, C.
    Ehninger, G.
    Thiede, C.
    ONKOLOGIE, 2011, 34 : 298 - 298
  • [9] Immunophenotypic Abnormalities in Acute Myeloid Leukemia Associated with NPM1 Mutation and Clinical Significance of Minimal Residual Disease Detection
    Zhou, Yi
    Wu, David
    Chen, Xueyan
    Fromm, Jonathan R.
    Wood, Brent L.
    MODERN PATHOLOGY, 2016, 29 : 387A - 388A
  • [10] Immunophenotypic Abnormalities in Acute Myeloid Leukemia Associated with NPM1 Mutation and Clinical Significance of Minimal Residual Disease Detection
    Zhou, Yi
    Wu, David
    Chen, Xueyan
    Fromm, Jonathan R.
    Wood, Brent L.
    LABORATORY INVESTIGATION, 2016, 96 : 387A - 388A
12345